Impacts of medicine shortages on community pharmacies Europe 2022

According to a survey conducted during November and December 2022, nearly 76 percent of European countries who reported experiencing medicine shortages in their countries during the last 12 months reported reduced employee satisfaction in community pharmacies as a result. This graph shows the impacts of medicine shortages on community pharmacies in European countries who reported medicine shortages.

Impacts of medicine shortages on community pharmacies in European countries who reported medicine shortages as of 2022

Characteristic	Percentage of respondent countries
Financial loss due to time invested in mitigating shortages	96.6%
Reduced employee satisfaction	75.9%
Reduced patient/customer trust	75.9%
Increased administrative duties	75.9%
Financial loss due to needed operational changes such as minimum stock keeping, import fees, etc.	55.2%
Direct financial loss due to increased sourcing prices as a reaction to low availability of a certain medicine	55.2%

Loading statistic...

Download

Source

Show detailed source information?

Already a member?

Source

Use Ask Statista Research Service

Release date

2023

More information

Region

Europe

Survey time period

November 14 to December 31, 2022

Number of respondents

29 PGEU member countries

Supplementary notes

Original question: "In your opinion, how have medicines shortages affected community pharmacies in your country? Tick all that apply."
PGEU member countries who participated in the survey include Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Kosovo, Latvia, Luxembourg, Netherlands, North Macedonia, Norway, Portugal, Romania, Serbia, Slovakia, Slovenia, Spain, Sweden, Turkey.
Medicine shortage was defined as every (temporary) inability for a community or hospital pharmacy to supply patients with the medicinal product requested as a result of factors beyond their control, requiring the dispensing of an alternative agent or even discontinuation of an ongoing medical therapy.

Citation formats